Exploring Predictors of Quality of Life in Older Adults With End-Stage Kidney Disease Receiving In-Center Hemodialysis

NCT ID: NCT07129083

Last Updated: 2025-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

111 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2025-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This cross-sectional observational study investigates the overall quality of life (QoL) in adults aged 65 and older receiving in-center hemodialysis. While health-related quality of life (HRQoL) is commonly used in nephrology, it may not fully reflect what matters most to older patients. Using the Amnestic Comparative Self-Assessment (ACSA) as the primary measure, this study explores key determinants of QoL and examines how it relates to existing HRQoL tools (EQ-5D-3L, EORTC QLQ-C30, QLQ-MY20). Data are collected from four hospitals in Flanders, Belgium, using psychosocial (geriatric) assessments. Statistical analysis includes regression and cluster methods to identify predictors and patient subgroups. Results aim to inform more patient-centered care and improve QoL measurement in dialysis research.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The global prevalence of end-stage kidney disease (ESKD) is steadily rising, with older adults representing the fastest-growing demographic in this patient population. In Europe, individuals aged 65 and older now account for over 52% of all incident ESKD cases. The primary treatment modality, in-center hemodialysis (ICHD), although life-sustaining, imposes a considerable treatment burden. This burden, when combined with the inherent symptom load of advanced kidney disease, often leads to a significant reduction in patients' overall well-being.

Compared to their younger counterparts, older adults on dialysis experience more complex clinical trajectories, characterized by multi-morbidity, increased frailty, and psychosocial vulnerability. Moreover, this population often faces challenges in adhering to the demanding schedules and lifestyle restrictions associated with dialysis. These factors collectively contribute to a reduction in overall quality of life (QoL), which patients often prioritize even over life expectancy.

Numerous studies have demonstrated that many older dialysis patients are willing to trade significant lengths of life expectancy, up to nine years in some cases, in exchange for better QoL. Despite this, QoL remains a vastly underutilized metric in nephrology clinical research. Only a small fraction of randomized controlled trials include QoL as an outcome measure, and even fewer consider it as a primary endpoint.

Health-Related Quality of Life (HRQoL), a narrower construct within the broader domain of QoL, is often used as a proxy for evaluating the well-being of patients. However, HRQoL tools may not fully capture what matters most to patients, especially during major life transitions such as dialysis initiation. Furthermore, differences in HRQoL instruments can produce inconsistent evaluations of patient outcomes and influence the estimation of quality-adjusted life years (QALYs), potentially skewing health policy decisions.

In light of these concerns, there is a need to examine overall QoL among older adults receiving dialysis, moving beyond standard HRQoL assessments to capture a more holistic and patient-centered understanding of life quality in this vulnerable population.

This study aims to:

* Identify the key determinants of overall QoL in older adults undergoing ICHD.
* Examine how overall QoL relates to existing HRQoL measures.
* Evaluate whether existing HRQoL instruments adequately capture domains that are meaningful to this population.
* Explore natural groupings (clusters) of patients based on QoL and associated variables to inform future patient-centered interventions.

Study Design This is a cross-sectional, observational study reported in accordance with the Strengthening The Reporting of Observational Studies in Epidemiology (STROBE) guidelines. The study involves quantitative data collection through a structured assessment set administered face-to-face during dialysis sessions.

Participants are recruited from four hospitals in the Flanders region of Belgium between January and April 2018. Hospitals are selected to ensure a representative sample across urban, rural, academic, and regional settings.

Eligibility criteria include:

Age ≥65 years Receiving ICHD Able to provide informed consent Sufficient cognitive and language capacity to complete the questionnaire in Dutch

Exclusion criteria include:

Receiving dialysis due to an acute hospital admission Diagnosed with severe psychiatric or cognitive disorders (e.g., dementia) as documented in the medical record

Data Collection and Outcome Measures A total of 95 variables are assessed across multiple domains, guided by the International Classification of Functioning, Disability and Health (ICF) framework. Assessments are conducted during one to three consecutive dialysis sessions, depending on each participant's physical and cognitive condition. Each session lasts approximately 45 minutes.

An independent researcher with no clinical ties to the patient or dialysis unit conducts all interviews to reduce bias and minimize socially desirable responses.

Primary Outcome Measure Amnestic Comparative Self-Assessment (ACSA): A self-anchoring QoL rating scale ranging from -5 (worst period of life) to +5 (best period), based on the individual's life experiences. Participants reflect on the most positive and negative periods of their life and rate their current quality of life relative to these anchors. This tool allows for a highly individualized and sensitive measure of overall QoL.

Secondary Measures (Independent Variables) Sociodemographic Variables: Age, sex, education level, marital status, living situation Dialysis-Related Variables: Duration of dialysis, comorbidity index, dialysis adequacy Comprehensive Geriatric Assessment (CGA): Functional, psychological, and social domains including Fall Risk: STRATIFY scale, Psychological Measures: Geriatric Depression Scale (GDS-4), Nutritional Status: Nutritional Risk Screening (NRS-2002) Frailty Assessment: Groningen Frailty Indicator (GFI) Functional Status: Brussels Integrated Activity Scale (BIA) - measuring basic, instrumental, and advanced ADLs

HRQoL Instruments:

EuroQol 5-Dimension 3-Level Questionnaire (EQ-5D-3L) European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) EORTC QLQ-Myeloma Module (QLQ-MY20)

Statistical Analysis

All data are analyzed using SPSS (version 29.0.2.0). Missing values are handled using listwise deletion per questionnaire. The analysis is carried out in four stages:

1. Descriptive Statistics: Means and standard deviations for normally distributed variables, medians and interquartile ranges for non-normal distributions. Normality assessed via Shapiro-Wilk test.
2. Univariate Analyses:

Mann-Whitney U test for dichotomous variables Kruskal-Wallis test for categorical variables with more than two groups Spearman's correlation for continuous and ordinal variables
3. Multivariate Regression: Variables significantly associated with ACSA scores in univariate analysis are entered into a stepwise linear regression model to identify independent predictors of QoL.
4. Cluster Analysis: Hierarchical clustering (Ward's method) is used to determine optimal grouping, followed by K-means clustering to explore patterns of QoL across patient subgroups.

Ethical Considerations This study was reviewed and approved by the Ethical Committee of Ghent University Hospital (B670201837264). All participants are fully informed of the study's purpose and procedures and provided both written and verbal informed consent. The study complies with the Declaration of Helsinki on ethical principles for medical research involving human subjects.

Significance and Expected Outcomes

This study offers an exploration of overall QoL in older adults receiving hemodialysis. By using the ACSA alongside commonly used HRQoL instruments and a wide range of biopsychosocial variables, the findings will help:

1. Clarify which factors most strongly influence QoL in this population
2. Reveal potential mismatches between standardized HRQoL measures and patients' lived experiences
3. Inform future intervention design focused on improving well-being, not just clinical outcomes
4. Provide empirical evidence to guide the choice of QoL instruments in research and policy evaluation, including cost-effectiveness studies

Ultimately, the study is expected to contribute to more patient-centered care models and improve the integration of QoL measures into nephrology research and clinical practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Failure, Hemodialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Older adults receiving in-center hemodialysis

Adults aged 65 years and older undergoing maintenance in-center hemodialysis at four hospitals in Flanders, Belgium. Participants completed structured assessments covering overall quality of life, health-related quality of life, clinical, functional, psychological, and sociodemographic variables.

Structured assessment interview

Intervention Type OTHER

Participants completed a structured, in-person assessment conducted during one to three dialysis sessions. The assessment included validated instruments to measure overall quality of life (ACSA), health-related quality of life (EQ-5D-3L, EORTC QLQ-C30, QLQ-MY20), and various clinical, psychological, functional, and sociodemographic factors.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Structured assessment interview

Participants completed a structured, in-person assessment conducted during one to three dialysis sessions. The assessment included validated instruments to measure overall quality of life (ACSA), health-related quality of life (EQ-5D-3L, EORTC QLQ-C30, QLQ-MY20), and various clinical, psychological, functional, and sociodemographic factors.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 65 years or older
* Receiving maintenance in-center hemodialysis (ICHD)
* Able to provide informed consent
* Sufficient cognitive capacity to understand and answer study questions
* Fluent in Dutch (able to complete assessments in Dutch)

Exclusion Criteria

* Receiving ICHD due to an acute hospital admission (not chronic treatment)
* Documented diagnosis of severe psychiatric illness or severe cognitive impairment (e.g., dementia)
* Unable to understand or respond adequately to the questionnaire
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Ghent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dominique Van d Van de Velde, Doctorate

Role: PRINCIPAL_INVESTIGATOR

University Ghent

Wim Van Biesen, Doctorate, MD

Role: STUDY_DIRECTOR

University Ghent

Patricia De Vriendt, Doctorate

Role: STUDY_CHAIR

University Ghent

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ghent University Hospital

Ghent, Oost-Vlaanderen, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BC-11716

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Kidney Health: Eat Well, Live Well
NCT05970341 RECRUITING NA
Effect of Exercise on Renal Function in Predialysis
NCT02155036 COMPLETED PHASE1/PHASE2